Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. IJ Radiology
  4. Articles

  5. Radiologic Findings of Ductal Carcinoma in Situ Arising Within a Juvenile Fibroadenoma: Mammographic, Sonographic and Dynamic Contrast-Enhanced Breast MRI Features
  6. Scopus by Title (Ref)

IJ Radiology

An Innovative Journal in the Field of Radiology

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors and BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Invasive carcinoma in recurrent breast fibroadenoma: a case report and literature review

- Ho M.Y. , et al.

2. Low diffusion level within a fibroadenoma as the sole sign of ductal carcinoma in situ: A case report

- Tagliati C. , et al.

3. Ductal carcinoma in situ (DCIS) in breast fibroadenoma

- El-Essawy M. , et al.

4. Fibroadenomas and breast carcinoma: A possible answer to a frequently asked question. A pictorial essay

- Ciurea A. , et al.

5. An application study of low-dose computed tomography perfusion imaging (LDCTPI) in breast cancer and breast fibroadenoma

- Cheng Y.G. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors and Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.